Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants

被引：0
|
作者：
Steven J. Smith
Gary T. Pauly
Aamir Akram
Kevin Melody
Ganesha Rai
David J. Maloney
Zandrea Ambrose
Craig J. Thomas
Joel T. Schneider
Stephen H. Hughes
机构：
[1] National Institutes of Health,HIV Drug Resistance Program, National Cancer Institute
[2] National Institutes of Health,Frederick
[3] University of Pittsburgh,Chemical Biology Laboratory, National Cancer Institute
[4] University of Pittsburgh,Frederick
[5] NIH,Department of Infectious Diseases and Microbiology, Graduate School of Public Health
来源：
Retrovirology | / 13卷
关键词：
HIV-1; Nonnucleoside reverse transcriptase inhibitors; Rilpivirine; Antiviral activity; Resistance; Analogs; Susceptibility; Binding pocket; Doravirine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Drug-resistant HIV-1 in Cuban Children and their Seropositive Mothers
    Perez, Lissette
    Correa, Consuelo
    Aleman, Joan
    Gonzalez, Ida
    Perez, Jorge
    Martinez, Pedro A.
    Alvarez, Alina
    Soto, Yudiro
    Kouri, Vivian
    MEDICC REVIEW, 2011, 13 (02) : 24 - 31
  • [32] A RAPID SCREEN FOR DRUG-RESISTANT HIV PROTEASE MUTANTS
    CONDRA, JH
    EMINI, EA
    GOTLIB, L
    GRAHAM, DJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 76 - 76
  • [33] INSTIs and NNRTIs Potently Inhibit HIV-1 Polypurine Tract Mutants in a Single Round Infection Assay
    Smith, Steven J.
    Ferris, Andrea
    Zhao, Xuezhi
    Pauly, Gary
    Schneider, Joel P.
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    VIRUSES-BASEL, 2021, 13 (12):
  • [34] Overcoming drug resistance in HIV-1 chemotherapy:: The binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease
    Ohtaka, H
    Velázquez-Campoy, A
    Xie, D
    Freire, E
    PROTEIN SCIENCE, 2002, 11 (08) : 1908 - 1916
  • [35] Taking aim at a rapidly evolving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases
    Arnold, E
    FASEB JOURNAL, 2006, 20 (05): : A1306 - A1306
  • [36] Dioxolane-thymine nucleoside (DOT) against drug-resistant HIV-1 mutants and its molecular mechanism
    Chu, CK
    Chong, YH
    Schinazi, RF
    ANTIVIRAL THERAPY, 2004, 9 (04) : U30 - U31
  • [37] Change in the Prevalence of HIV-1 and the Rate of Transmitted Drug-Resistant HIV-1 in Haiphong, Northern Vietnam
    Hung Viet Pham
    Ishizaki, Azumi
    Cuong Hung Nguyen
    Saina, Matilda Chelimo
    Huyen Thi Thanh Hoang
    Vuong Thi Tran
    Bi, Xiuqiong
    Thuc Van Pham
    Ichimura, Hiroshi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (07) : 757 - 759
  • [38] Structural and kinetic analysis of drug resistant mutants of HIV-1 protease
    Mahalingam, B
    Louis, JM
    Reed, CC
    Adomat, JM
    Krouse, J
    Wang, YF
    Harrison, RW
    Weber, IT
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (01): : 238 - 245
  • [39] Epidemiology of drug-resistant HIV-1 transmission in naive patients in Spain
    Yebra, Gonzalo
    Holguin, Africa
    MEDICINA CLINICA, 2010, 135 (12): : 561 - 567
  • [40] Detection of minor populations of drug-resistant HIV-1 in acute seroconverters
    Metzner, KJ
    Rauch, P
    Walter, H
    Boesecke, C
    Zöllner, B
    Jessen, H
    Schewe, K
    Fenske, S
    Gellermann, H
    Stellbrink, HJ
    ANTIVIRAL THERAPY, 2005, 10 : S123 - S123
12345